These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10186679)

  • 1. A tripartite regulation of health networks.
    Weil TP; Jorgensen NE
    J Public Health Manag Pract; 1996; 2(3):46-53. PubMed ID: 10186679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tripartite regulation of America's health services.
    Weil TP; Jorgensen NE
    Spectrum; 1996; 69(1):39-43. PubMed ID: 10156001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managed care merged with the German model.
    Weil TP
    Am J Med Qual; 1997; 12(1):19-24. PubMed ID: 9116526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why market-driven forces in our health industry might eventually stumble: what could happen then?
    Weil TP; Jorgensen NE
    J Health Care Finance; 1995; 22(2):1-12. PubMed ID: 8820294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State health services commissions German style.
    Weil TP
    Hosp Top; 1995; 73(4):29-35. PubMed ID: 10154280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How health networks and HMOs could result in public utility regulation.
    Weil T
    Hosp Health Serv Adm; 1996; 41(2):266-80. PubMed ID: 10157967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rural health network development: public policy issues and state initiatives.
    Casey MM; Wellever A; Moscovice I
    J Health Polit Policy Law; 1997 Feb; 22(1):23-47. PubMed ID: 9057120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternatives for clinical integration: antitrust law considerations.
    Buchanan RM
    Int Ophthalmol Clin; 1998; 38(3):27-44. PubMed ID: 9742431
    [No Abstract]   [Full Text] [Related]  

  • 10. Powerful networks could result in public utility-style regulation of health care.
    Weil TP
    Healthspan; 1995 Feb; 12(2):12-5. PubMed ID: 10166119
    [No Abstract]   [Full Text] [Related]  

  • 11. As more and more doctors join physician groups, antitrust experts wonder whether hospitals and health plans will be ... outgunned.
    Jaklevic MC
    Mod Healthc; 1997 Nov; 27(46):38-40. PubMed ID: 10174358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical approach for analyzing antitrust issues faced by provider networks.
    Ross DC
    J Health Hosp Law; 1997; 30(3):133-45. PubMed ID: 10179111
    [No Abstract]   [Full Text] [Related]  

  • 13. Interpreting the 1996 federal antitrust guidelines for physician joint venture networks.
    Hirshfeld E
    Ann Health Law; 1997; 6():1-49. PubMed ID: 10173274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing physician networks within evolving antitrust guidelines.
    Retchin TN; Retchin SM
    Clin Perform Qual Health Care; 1997; 5(3):140-5. PubMed ID: 10169186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitrust, competition, and health care reform.
    Bloch RE; Falk DM
    Health Aff (Millwood); 1994; 13(1):206-23. PubMed ID: 8188136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicaid managed care and the family planning free-choice exemption: beyond the freedom to choose.
    Rosenbaum S; Shin PW; Mauskopf A; Zuvekas A
    J Health Polit Policy Law; 1997 Oct; 22(5):1191-214. PubMed ID: 9394245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserving antitrust.
    O'Neil-White A; Wilber K
    HMO; 1995; 36(3):15-7. PubMed ID: 10166472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitrust evaluation of physician networks.
    Rosen BF; Dietz RL
    Md Med J; 1996 Aug; 45(8):611-3. PubMed ID: 8772273
    [No Abstract]   [Full Text] [Related]  

  • 19. Physician practice integration and consolidation: an antitrust enforcement perspective.
    Wessler SL
    Int Ophthalmol Clin; 1998; 38(3):45-57. PubMed ID: 9742432
    [No Abstract]   [Full Text] [Related]  

  • 20. Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation - Irreconcilable Differences?
    King MW
    Am J Law Med; 2017 Nov; 43(4):426-467. PubMed ID: 29452560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.